Effective specimen collection during the pivotal collection period guides everything that follows, from individual therapeutic decisions to large-scale community outbreak control. The post The 96-Hour Advantage: Why Early Diagnostic Accuracy Defines Clinical Outcomes appeared first on MedCity News.
This brief provides an explanation of Title 42 and its application in border regions, the impact of Title 42 on border expulsions and the health and well-being of migrants during COVID-19, and a discussion of the potential implications of reinvoking Title 42 restrictions for immigration and the health of migrants.
National Cancer Institute funding to help establish the Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center
Meals on Wheels American and the WellSky Foundation found an 85 percent decrease in hospitalizations 30 days after meal delivery service
Paxlovid (nirmatrelvir-ritonavir) is effective at preventing hospitalization and death from COVID-19, but few people use it. A paper by SteelFisher et al. (2024) surveyed 1,430 American adults to find out why. Their survey revealed patients had a lack of awareness of the treatment as well as misinformation about the treatment (among those who were aware…
Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Her doctor and several pharmacies turned her down because she was below the recommended…
In this episode, we’re joined by Kathryn Schubert, president and CEO of the Society for Women’s Health Research. Schubert discusses the trends in women’s health that defined 2024 and what we can expect in the coming year. The post MedCity FemFwd: What the Future Holds for Women’s Health in 2025 appeared first on MedCity News.
Much of today’s care infrastructure was built for a different era, when medicine focused on acute illnesses and short-term fixes. But neurodegenerative diseases don’t follow that script, and neither can we. We have the tools to build something better: care that stays with people, adapts to their needs, and helps them live not just longer,…
As economists offer up their best guesses for the US economy over the coming year, healthcare leaders know one thing for sure: no matter what happens, they need solid revenue cycle management (RCM) processes to remain financially sound and deliver high-quality care. Revenue cycle management connects the financial and clinical aspects of care by ensuring…
Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of companies developing bispecific antibodies for those targets, many of them with molecules originally developed in China. The post Pfizer Pledges $1.25B for Drug Candidate…